Therapeutic efficacy of silymarin and naringenin in reducing arsenic-induced hepatic damage in young rats

We investigated the effects of silymarin and naringenin in counteracting arsenic-induced hepatic oxidative stress post exposure. Male wistar rats were chronically exposed to sodium arsenite for eight months followed by oral treatment with silymarin and naringenin (50 mg/kg each) for 15 consecutive d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Ecotoxicology and environmental safety 2011-05, Vol.74 (4), p.607-614
Hauptverfasser: Jain, Anshu, Yadav, Abhishek, Bozhkov, A.I., Padalko, V.I., Flora, S.J.S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 614
container_issue 4
container_start_page 607
container_title Ecotoxicology and environmental safety
container_volume 74
creator Jain, Anshu
Yadav, Abhishek
Bozhkov, A.I.
Padalko, V.I.
Flora, S.J.S.
description We investigated the effects of silymarin and naringenin in counteracting arsenic-induced hepatic oxidative stress post exposure. Male wistar rats were chronically exposed to sodium arsenite for eight months followed by oral treatment with silymarin and naringenin (50 mg/kg each) for 15 consecutive days to evaluate hepatic damage and antioxidant potential. Our results demonstrate a significant decrease in hepatic GSH levels, SOD and catalase activities and an increase in GST and TBARS levels after arsenic administration. Silymarin or naringenin administration increased GSH levels and was beneficial in the recovery of altered SOD and catalase activity besides significantly reducing blood and tissue arsenic concentration. Our results point to the antioxidant potential of these flavonoids, which might be of benefit in the clinical recovery of subject exposed to arsenic. These flavonoids can be incorporated into the diet or co-supplemented during chelation treatment, and thus may afford a protective effect against arsenite-induced cytotoxicity.
doi_str_mv 10.1016/j.ecoenv.2010.08.002
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_883041319</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0147651310001995</els_id><sourcerecordid>865695552</sourcerecordid><originalsourceid>FETCH-LOGICAL-c546t-86397a3b03ddc9100ea47c50817d2a1f96bbfe609cfd2cfa9ac02f24fa94b9f43</originalsourceid><addsrcrecordid>eNqFkd2L1DAQwIMo3nr6H4j2RfSl6-SrbV4O5PALDnzw7jlM08lelm67Ju3B_vemdNW3EwKZGX6ZSfJj7DWHLQdefdxvyY00PGwF5BI0WwDxhG04GCiF4uop2wBXdVlpLi_Yi5T2ACBB6-fsQkDNjWz0hoXbe4p4pHkKriDvg0N3KkZfpNCfDhjDUODQFcMS7WjIaV6RutnlvMCYcs2VYcgF6op7OuLSqMMD7mhBT-OcuYhTesmeeewTvTrvl-zuy-fb62_lzY-v368_3ZROq2oqm0qaGmULsuuc4QCEqnYaGl53Ark3Vdt6qsA43wnn0aAD4YXKkWqNV_KSvV_7HuP4a6Y02UNIjvoeBxrnZJtGguIyv_-_ZKUro7UWmfzwKMnruuZCSQ0ZVSvq4phSJG-PMeSPPFkOdhFn93YVZxdxFhqbxeVjb84T5vZA3d9Df0xl4N0ZwOSw9xEHF9I_TglulFoavV05j6PFXczM3c88SQFww2VVZ-JqJShbeAgUbXKBhuwvRHKT7cbw-F1_Ax2fwjI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1777124350</pqid></control><display><type>article</type><title>Therapeutic efficacy of silymarin and naringenin in reducing arsenic-induced hepatic damage in young rats</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Jain, Anshu ; Yadav, Abhishek ; Bozhkov, A.I. ; Padalko, V.I. ; Flora, S.J.S.</creator><creatorcontrib>Jain, Anshu ; Yadav, Abhishek ; Bozhkov, A.I. ; Padalko, V.I. ; Flora, S.J.S.</creatorcontrib><description>We investigated the effects of silymarin and naringenin in counteracting arsenic-induced hepatic oxidative stress post exposure. Male wistar rats were chronically exposed to sodium arsenite for eight months followed by oral treatment with silymarin and naringenin (50 mg/kg each) for 15 consecutive days to evaluate hepatic damage and antioxidant potential. Our results demonstrate a significant decrease in hepatic GSH levels, SOD and catalase activities and an increase in GST and TBARS levels after arsenic administration. Silymarin or naringenin administration increased GSH levels and was beneficial in the recovery of altered SOD and catalase activity besides significantly reducing blood and tissue arsenic concentration. Our results point to the antioxidant potential of these flavonoids, which might be of benefit in the clinical recovery of subject exposed to arsenic. These flavonoids can be incorporated into the diet or co-supplemented during chelation treatment, and thus may afford a protective effect against arsenite-induced cytotoxicity.</description><identifier>ISSN: 0147-6513</identifier><identifier>EISSN: 1090-2414</identifier><identifier>DOI: 10.1016/j.ecoenv.2010.08.002</identifier><identifier>PMID: 20719385</identifier><identifier>CODEN: EESADV</identifier><language>eng</language><publisher>San Diego, CA: Elsevier Inc</publisher><subject>Animal, plant and microbial ecology ; Animals ; antioxidant activity ; Antioxidants ; Antioxidants - pharmacology ; Antioxidants - therapeutic use ; Applied ecology ; Arsenic ; Arsenic - metabolism ; Arsenic Poisoning - drug therapy ; Arsenic Poisoning - metabolism ; Arsenic toxicity ; Arsenites - toxicity ; Biological and medical sciences ; blood ; Catalase ; Catalase - metabolism ; Chelating Agents - therapeutic use ; Chelation ; Chemical and Drug Induced Liver Injury - drug therapy ; Chemical and Drug Induced Liver Injury - metabolism ; chronic exposure ; cytotoxicity ; Damage ; Ecotoxicology, biological effects of pollution ; Environmental Pollutants - metabolism ; Flavanones - pharmacology ; Flavanones - therapeutic use ; Flavonoids ; Fundamental and applied biological sciences. Psychology ; General aspects ; Glutathione - metabolism ; Glutathione Peroxidase - metabolism ; Glutathione Transferase - metabolism ; Lipid Peroxidation - drug effects ; Liver - drug effects ; Liver - metabolism ; Male ; Naringenin ; oral administration ; Oxidative stress ; Oxidative Stress - drug effects ; protective effect ; Rat ; Rats ; Rats, Wistar ; Reactive Oxygen Species - metabolism ; Recovery ; Silymarin ; Silymarin - pharmacology ; Silymarin - therapeutic use ; Sod ; sodium arsenite ; Sodium Compounds - toxicity ; superoxide dismutase ; Superoxide Dismutase - metabolism ; Thiobarbituric Acid Reactive Substances - metabolism ; thiobarbituric acid-reactive substances ; Tissue arsenic concentration</subject><ispartof>Ecotoxicology and environmental safety, 2011-05, Vol.74 (4), p.607-614</ispartof><rights>2010 Elsevier Inc.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2010 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c546t-86397a3b03ddc9100ea47c50817d2a1f96bbfe609cfd2cfa9ac02f24fa94b9f43</citedby><cites>FETCH-LOGICAL-c546t-86397a3b03ddc9100ea47c50817d2a1f96bbfe609cfd2cfa9ac02f24fa94b9f43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ecoenv.2010.08.002$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=24219442$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20719385$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jain, Anshu</creatorcontrib><creatorcontrib>Yadav, Abhishek</creatorcontrib><creatorcontrib>Bozhkov, A.I.</creatorcontrib><creatorcontrib>Padalko, V.I.</creatorcontrib><creatorcontrib>Flora, S.J.S.</creatorcontrib><title>Therapeutic efficacy of silymarin and naringenin in reducing arsenic-induced hepatic damage in young rats</title><title>Ecotoxicology and environmental safety</title><addtitle>Ecotoxicol Environ Saf</addtitle><description>We investigated the effects of silymarin and naringenin in counteracting arsenic-induced hepatic oxidative stress post exposure. Male wistar rats were chronically exposed to sodium arsenite for eight months followed by oral treatment with silymarin and naringenin (50 mg/kg each) for 15 consecutive days to evaluate hepatic damage and antioxidant potential. Our results demonstrate a significant decrease in hepatic GSH levels, SOD and catalase activities and an increase in GST and TBARS levels after arsenic administration. Silymarin or naringenin administration increased GSH levels and was beneficial in the recovery of altered SOD and catalase activity besides significantly reducing blood and tissue arsenic concentration. Our results point to the antioxidant potential of these flavonoids, which might be of benefit in the clinical recovery of subject exposed to arsenic. These flavonoids can be incorporated into the diet or co-supplemented during chelation treatment, and thus may afford a protective effect against arsenite-induced cytotoxicity.</description><subject>Animal, plant and microbial ecology</subject><subject>Animals</subject><subject>antioxidant activity</subject><subject>Antioxidants</subject><subject>Antioxidants - pharmacology</subject><subject>Antioxidants - therapeutic use</subject><subject>Applied ecology</subject><subject>Arsenic</subject><subject>Arsenic - metabolism</subject><subject>Arsenic Poisoning - drug therapy</subject><subject>Arsenic Poisoning - metabolism</subject><subject>Arsenic toxicity</subject><subject>Arsenites - toxicity</subject><subject>Biological and medical sciences</subject><subject>blood</subject><subject>Catalase</subject><subject>Catalase - metabolism</subject><subject>Chelating Agents - therapeutic use</subject><subject>Chelation</subject><subject>Chemical and Drug Induced Liver Injury - drug therapy</subject><subject>Chemical and Drug Induced Liver Injury - metabolism</subject><subject>chronic exposure</subject><subject>cytotoxicity</subject><subject>Damage</subject><subject>Ecotoxicology, biological effects of pollution</subject><subject>Environmental Pollutants - metabolism</subject><subject>Flavanones - pharmacology</subject><subject>Flavanones - therapeutic use</subject><subject>Flavonoids</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>General aspects</subject><subject>Glutathione - metabolism</subject><subject>Glutathione Peroxidase - metabolism</subject><subject>Glutathione Transferase - metabolism</subject><subject>Lipid Peroxidation - drug effects</subject><subject>Liver - drug effects</subject><subject>Liver - metabolism</subject><subject>Male</subject><subject>Naringenin</subject><subject>oral administration</subject><subject>Oxidative stress</subject><subject>Oxidative Stress - drug effects</subject><subject>protective effect</subject><subject>Rat</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Recovery</subject><subject>Silymarin</subject><subject>Silymarin - pharmacology</subject><subject>Silymarin - therapeutic use</subject><subject>Sod</subject><subject>sodium arsenite</subject><subject>Sodium Compounds - toxicity</subject><subject>superoxide dismutase</subject><subject>Superoxide Dismutase - metabolism</subject><subject>Thiobarbituric Acid Reactive Substances - metabolism</subject><subject>thiobarbituric acid-reactive substances</subject><subject>Tissue arsenic concentration</subject><issn>0147-6513</issn><issn>1090-2414</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkd2L1DAQwIMo3nr6H4j2RfSl6-SrbV4O5PALDnzw7jlM08lelm67Ju3B_vemdNW3EwKZGX6ZSfJj7DWHLQdefdxvyY00PGwF5BI0WwDxhG04GCiF4uop2wBXdVlpLi_Yi5T2ACBB6-fsQkDNjWz0hoXbe4p4pHkKriDvg0N3KkZfpNCfDhjDUODQFcMS7WjIaV6RutnlvMCYcs2VYcgF6op7OuLSqMMD7mhBT-OcuYhTesmeeewTvTrvl-zuy-fb62_lzY-v368_3ZROq2oqm0qaGmULsuuc4QCEqnYaGl53Ark3Vdt6qsA43wnn0aAD4YXKkWqNV_KSvV_7HuP4a6Y02UNIjvoeBxrnZJtGguIyv_-_ZKUro7UWmfzwKMnruuZCSQ0ZVSvq4phSJG-PMeSPPFkOdhFn93YVZxdxFhqbxeVjb84T5vZA3d9Df0xl4N0ZwOSw9xEHF9I_TglulFoavV05j6PFXczM3c88SQFww2VVZ-JqJShbeAgUbXKBhuwvRHKT7cbw-F1_Ax2fwjI</recordid><startdate>20110501</startdate><enddate>20110501</enddate><creator>Jain, Anshu</creator><creator>Yadav, Abhishek</creator><creator>Bozhkov, A.I.</creator><creator>Padalko, V.I.</creator><creator>Flora, S.J.S.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SU</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>KR7</scope><scope>7X8</scope><scope>7ST</scope><scope>7T2</scope><scope>7U2</scope><scope>7U7</scope><scope>SOI</scope></search><sort><creationdate>20110501</creationdate><title>Therapeutic efficacy of silymarin and naringenin in reducing arsenic-induced hepatic damage in young rats</title><author>Jain, Anshu ; Yadav, Abhishek ; Bozhkov, A.I. ; Padalko, V.I. ; Flora, S.J.S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c546t-86397a3b03ddc9100ea47c50817d2a1f96bbfe609cfd2cfa9ac02f24fa94b9f43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Animal, plant and microbial ecology</topic><topic>Animals</topic><topic>antioxidant activity</topic><topic>Antioxidants</topic><topic>Antioxidants - pharmacology</topic><topic>Antioxidants - therapeutic use</topic><topic>Applied ecology</topic><topic>Arsenic</topic><topic>Arsenic - metabolism</topic><topic>Arsenic Poisoning - drug therapy</topic><topic>Arsenic Poisoning - metabolism</topic><topic>Arsenic toxicity</topic><topic>Arsenites - toxicity</topic><topic>Biological and medical sciences</topic><topic>blood</topic><topic>Catalase</topic><topic>Catalase - metabolism</topic><topic>Chelating Agents - therapeutic use</topic><topic>Chelation</topic><topic>Chemical and Drug Induced Liver Injury - drug therapy</topic><topic>Chemical and Drug Induced Liver Injury - metabolism</topic><topic>chronic exposure</topic><topic>cytotoxicity</topic><topic>Damage</topic><topic>Ecotoxicology, biological effects of pollution</topic><topic>Environmental Pollutants - metabolism</topic><topic>Flavanones - pharmacology</topic><topic>Flavanones - therapeutic use</topic><topic>Flavonoids</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>General aspects</topic><topic>Glutathione - metabolism</topic><topic>Glutathione Peroxidase - metabolism</topic><topic>Glutathione Transferase - metabolism</topic><topic>Lipid Peroxidation - drug effects</topic><topic>Liver - drug effects</topic><topic>Liver - metabolism</topic><topic>Male</topic><topic>Naringenin</topic><topic>oral administration</topic><topic>Oxidative stress</topic><topic>Oxidative Stress - drug effects</topic><topic>protective effect</topic><topic>Rat</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Recovery</topic><topic>Silymarin</topic><topic>Silymarin - pharmacology</topic><topic>Silymarin - therapeutic use</topic><topic>Sod</topic><topic>sodium arsenite</topic><topic>Sodium Compounds - toxicity</topic><topic>superoxide dismutase</topic><topic>Superoxide Dismutase - metabolism</topic><topic>Thiobarbituric Acid Reactive Substances - metabolism</topic><topic>thiobarbituric acid-reactive substances</topic><topic>Tissue arsenic concentration</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jain, Anshu</creatorcontrib><creatorcontrib>Yadav, Abhishek</creatorcontrib><creatorcontrib>Bozhkov, A.I.</creatorcontrib><creatorcontrib>Padalko, V.I.</creatorcontrib><creatorcontrib>Flora, S.J.S.</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Environmental Engineering Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Civil Engineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Environment Abstracts</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Safety Science and Risk</collection><collection>Toxicology Abstracts</collection><collection>Environment Abstracts</collection><jtitle>Ecotoxicology and environmental safety</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jain, Anshu</au><au>Yadav, Abhishek</au><au>Bozhkov, A.I.</au><au>Padalko, V.I.</au><au>Flora, S.J.S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Therapeutic efficacy of silymarin and naringenin in reducing arsenic-induced hepatic damage in young rats</atitle><jtitle>Ecotoxicology and environmental safety</jtitle><addtitle>Ecotoxicol Environ Saf</addtitle><date>2011-05-01</date><risdate>2011</risdate><volume>74</volume><issue>4</issue><spage>607</spage><epage>614</epage><pages>607-614</pages><issn>0147-6513</issn><eissn>1090-2414</eissn><coden>EESADV</coden><abstract>We investigated the effects of silymarin and naringenin in counteracting arsenic-induced hepatic oxidative stress post exposure. Male wistar rats were chronically exposed to sodium arsenite for eight months followed by oral treatment with silymarin and naringenin (50 mg/kg each) for 15 consecutive days to evaluate hepatic damage and antioxidant potential. Our results demonstrate a significant decrease in hepatic GSH levels, SOD and catalase activities and an increase in GST and TBARS levels after arsenic administration. Silymarin or naringenin administration increased GSH levels and was beneficial in the recovery of altered SOD and catalase activity besides significantly reducing blood and tissue arsenic concentration. Our results point to the antioxidant potential of these flavonoids, which might be of benefit in the clinical recovery of subject exposed to arsenic. These flavonoids can be incorporated into the diet or co-supplemented during chelation treatment, and thus may afford a protective effect against arsenite-induced cytotoxicity.</abstract><cop>San Diego, CA</cop><pub>Elsevier Inc</pub><pmid>20719385</pmid><doi>10.1016/j.ecoenv.2010.08.002</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0147-6513
ispartof Ecotoxicology and environmental safety, 2011-05, Vol.74 (4), p.607-614
issn 0147-6513
1090-2414
language eng
recordid cdi_proquest_miscellaneous_883041319
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Animal, plant and microbial ecology
Animals
antioxidant activity
Antioxidants
Antioxidants - pharmacology
Antioxidants - therapeutic use
Applied ecology
Arsenic
Arsenic - metabolism
Arsenic Poisoning - drug therapy
Arsenic Poisoning - metabolism
Arsenic toxicity
Arsenites - toxicity
Biological and medical sciences
blood
Catalase
Catalase - metabolism
Chelating Agents - therapeutic use
Chelation
Chemical and Drug Induced Liver Injury - drug therapy
Chemical and Drug Induced Liver Injury - metabolism
chronic exposure
cytotoxicity
Damage
Ecotoxicology, biological effects of pollution
Environmental Pollutants - metabolism
Flavanones - pharmacology
Flavanones - therapeutic use
Flavonoids
Fundamental and applied biological sciences. Psychology
General aspects
Glutathione - metabolism
Glutathione Peroxidase - metabolism
Glutathione Transferase - metabolism
Lipid Peroxidation - drug effects
Liver - drug effects
Liver - metabolism
Male
Naringenin
oral administration
Oxidative stress
Oxidative Stress - drug effects
protective effect
Rat
Rats
Rats, Wistar
Reactive Oxygen Species - metabolism
Recovery
Silymarin
Silymarin - pharmacology
Silymarin - therapeutic use
Sod
sodium arsenite
Sodium Compounds - toxicity
superoxide dismutase
Superoxide Dismutase - metabolism
Thiobarbituric Acid Reactive Substances - metabolism
thiobarbituric acid-reactive substances
Tissue arsenic concentration
title Therapeutic efficacy of silymarin and naringenin in reducing arsenic-induced hepatic damage in young rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T14%3A39%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Therapeutic%20efficacy%20of%20silymarin%20and%20naringenin%20in%20reducing%20arsenic-induced%20hepatic%20damage%20in%20young%20rats&rft.jtitle=Ecotoxicology%20and%20environmental%20safety&rft.au=Jain,%20Anshu&rft.date=2011-05-01&rft.volume=74&rft.issue=4&rft.spage=607&rft.epage=614&rft.pages=607-614&rft.issn=0147-6513&rft.eissn=1090-2414&rft.coden=EESADV&rft_id=info:doi/10.1016/j.ecoenv.2010.08.002&rft_dat=%3Cproquest_cross%3E865695552%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1777124350&rft_id=info:pmid/20719385&rft_els_id=S0147651310001995&rfr_iscdi=true